Wikisage, the free encyclopedia of the second generation, is digital heritage

Difference between revisions of "Drisapersen"

From Wikisage
Jump to navigation Jump to search
m (Links)
Line 5: Line 5:
 
==Links==
 
==Links==
 
[http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2019;volume=67;issue=3;spage=717;epage=723;aulast=Arora Duchenne muscular dystrophy: Still an incurable disease]
 
[http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2019;volume=67;issue=3;spage=717;epage=723;aulast=Arora Duchenne muscular dystrophy: Still an incurable disease]
 +
 +
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010191/
 +
Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study]
 +
 
{{refs}}
 
{{refs}}

Revision as of 23:28, 11 September 2019

An exon skipping experimental Medicine[1] [2] PRO051/GSK2402968 is considered an orphan drug Duchenne muscular distrophy

Links

Duchenne muscular dystrophy: Still an incurable disease

[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010191/ Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study]

References

References: